Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage.

Minami Y, Kudo M.

Dig Dis. 2012;30(6):592-7. doi: 10.1159/000343087. Epub 2012 Dec 13. Review.

PMID:
23258100
2.

Biliary drainage for obstructive jaundice caused by unresectable hepatocellular carcinoma: the endoscopic versus percutaneous approach.

Choi J, Ryu JK, Lee SH, Ahn DW, Hwang JH, Kim YT, Yoon YB, Han JK.

Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):636-42.

3.

Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma.

Sugiyama G, Okabe Y, Ishida Y, Saitou F, Kawahara R, Ishikawa H, Horiuchi H, Kinoshita H, Tsuruta O, Sata M.

World J Gastroenterol. 2014 Jun 14;20(22):6968-73. doi: 10.3748/wjg.v20.i22.6968.

4.

Are endoscopic or percutaneous biliary drainage effective for obstructive jaundice caused by hepatocellular carcinoma?

Cho HC, Lee JK, Lee KH, Lee KT, Paik S, Choo SW, Do YS, Choo IW.

Eur J Gastroenterol Hepatol. 2011 Mar;23(3):224-31. doi: 10.1097/MEG.0b013e3283436ff6.

PMID:
21228705
5.

Self-expandable metallic stents vs. plastic stents for endoscopic biliary drainage in hepatocellular carcinoma.

Chung KH, Lee SH, Park JM, Lee JM, Ahn DW, Ryu JK, Kim YT.

Endoscopy. 2015 Jun;47(6):508-16. doi: 10.1055/s-0034-1391304. Epub 2015 Jan 15.

PMID:
25590179
6.

Palliative treatment of unresectable hepatocellular carcinoma with obstructive jaundice using biliary drainage with subsequent transarterial chemoembolization.

Choi J, Ryu JK, Lee SH, Hwang JH, Ahn DW, Kim YT, Yoon YB, Yoon CJ, Kang SG, Chung JW.

J Palliat Med. 2013 Sep;16(9):1026-33. doi: 10.1089/jpm.2013.0067. Epub 2013 Jul 26.

PMID:
23888306
7.

Hepatocellular carcinoma presenting with obstructive jaundice.

Lai EC, Lau WY.

ANZ J Surg. 2006 Jul;76(7):631-6. Review.

PMID:
16813631
8.

Percutaneous metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma.

Hong HP, Kim SK, Seo TS.

J Vasc Interv Radiol. 2008 May;19(5):748-54. doi: 10.1016/j.jvir.2007.12.455. Epub 2008 Mar 17.

PMID:
18440465
9.

Interventional therapy of malignant obstructive jaundice.

Feng GH, Cai Y, Jia Z, Yang DQ, Chen H, Jin HC, Yu QH, Zhu W, Wang CX.

Hepatobiliary Pancreat Dis Int. 2003 May;2(2):300-2.

10.

Hepato-biliary-enteric stent drainage as palliative treatment for proximal malignant obstructive jaundice.

Pan H, Liang Z, Yin TS, Xie Y, Li DW.

Med Oncol. 2014 Mar;31(3):853. doi: 10.1007/s12032-014-0853-3. Epub 2014 Jan 24.

PMID:
24464214
11.

[Comparison of the therapeutic effects of PTBD and PTBS in treatment of malignant obstructive jaundice].

Bai AG, Zheng CS, Zhou GF, Liang HM, Feng GS.

Zhonghua Zhong Liu Za Zhi. 2010 Jun;32(6):456-8. Chinese.

PMID:
20819490
12.

Ten years single center experience in percutaneous transhepatic decompression of biliary tree in patients with malignant obstructive jaundice.

Garcarek J, Kurcz J, Guziński M, Janczak D, Sasiadek M.

Adv Clin Exp Med. 2012 Sep-Oct;21(5):621-32.

13.

[Malignant biliary obstruction, general review and clinical practice].

Bonnel D, André T, Mader B, Lefebvre JF, Bensoussan E, Liguory C.

Bull Cancer. 2013 May;100(5):443-52. doi: 10.1684/bdc.2013.1736. Review. French.

PMID:
23644517
14.

Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas.

Tsuyuguchi T, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, Furuse J, Saito H, Suyama M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Amano H, Miura F; Japanese Association of Biliary Surgery; Japanese Society of Hepato-Biliary-Pancreatic Surgery; Japan Society of Clinical Oncology.

J Hepatobiliary Pancreat Surg. 2008;15(1):69-73. doi: 10.1007/s00534-007-1282-x. Epub 2008 Feb 16.

15.

What is appropriate procedure for preoperative biliary drainage in patients with obstructive jaundice awaiting pancreaticoduodenectomy?

Park SY, Park CH, Cho SB, Lee WS, Kim JC, Cho CK, Joo YE, Kim HS, Choi SK, Rew JS.

Surg Laparosc Endosc Percutan Tech. 2011 Oct;21(5):344-8. doi: 10.1097/SLE.0b013e3182318d2f.

PMID:
22002271
16.

Stent implantation through rendezvous technique of PTBD and ERCP: the treatment of obstructive jaundice.

Liu YD, Wang ZQ, Wang XD, Yang YS, Linghu EQ, Wang WF, Li W, Cai FC.

J Dig Dis. 2007 Nov;8(4):198-202.

PMID:
17970876
17.

Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors.

Lee JW, Han JK, Kim TK, Choi BI, Park SH, Ko YH, Yoon CJ, Yeon KM.

Cardiovasc Intervent Radiol. 2002 May-Jun;25(3):176-9. Epub 2002 Mar 27.

PMID:
12058212
18.

Role of percutaneous transhepatic biliary drainage in patients with obstructive jaundice caused by local recurrence of gastric cancer.

Makino T, Fujitani K, Tsujinaka T, Hirao M, Kashiwazaki M, Nakamori S, Ikenaga M, Mishima H, Masuda N, Sawamura T.

Hepatogastroenterology. 2008 Jan-Feb;55(81):54-7.

PMID:
18507078
19.

Management of hepatocellular carcinoma presenting as obstructive jaundice.

Lau WY, Leung JW, Li AK.

Am J Surg. 1990 Sep;160(3):280-2.

PMID:
2168129
20.

Percutaneous transhepatic biliary drainage (PTBD) with or without stenting-complications, re-stent rate and a new risk stratification score.

Tapping CR, Byass OR, Cast JE.

Eur Radiol. 2011 Sep;21(9):1948-55. doi: 10.1007/s00330-011-2121-7. Epub 2011 May 1.

PMID:
21533867
Items per page

Supplemental Content

Write to the Help Desk